Shields, MD is a world-renowned eye oncologist who has worked extensively on ocular melanoma and retinoblastoma. Shields, MD, is head of the Eye Oncology Service at Wills Eye Hospital and professor of ophthalmology at Thomas Jefferson University in Philadelphia. He completed his ophthalmology training at Wills Eye in 1987 and later completed a training fellowship in ocular oncology, oculoplastic surgery and ophthalmic pathology. Dr.
Carol Lally Shields is the Director of the Eye Oncology Service at Wills Eye Hospital. She is a professor of ophthalmology at Thomas Jefferson University and a consultant at the Children's Hospital of Philadelphia. Shields, MD, is head of the Eye Oncology Service at Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University. Shields is the author or co-author of more than 1900 articles in major journals and more than 300 textbook chapters.
He has presented more than 900 conferences around the world and has received many distinguished national and international awards. Shields' work has included some of the most advanced and successful treatments in the field of eye oncology. Tumors of the eyelids, conjunctiva, retina, cornea and orbit are individually rare, so even the best ophthalmologists saw few cases. Carol Shields has contributed more than 1500 articles and chapters to the medical literature on eye cancer.
His work has saved the lives of hundreds of children at risk of spreading retinoblastoma and he continues to seek better ways to preserve the eye for these young patients. His special interests include pediatric eye cancer, such as retinoblastoma, as well as adult eye cancer, such as melanoma, conjunctival tumors, and orbital tumors. Wills Eye also has a network of seven multi-specialty outpatient surgery centers across the tri-state area. As Shields, 75, tells it, he was just an unassuming good boy with mediocre grades and little ambition who, through serendipity, ended up becoming a renowned specialist in eye cancer and director of eye oncology at the Wills Eye Institute in Philadelphia.
Moster, MD, is Professor of Ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University and adjunct glaucoma surgeon at Wills Eye Hospital. She is an advocate for early treatment for intraocular melanoma and has been able to save many eyes with this disease using a tiny, custom-designed radiation therapy device to irradiate and resolve intraocular cancer. PHILADELPHIA, PA — Ten notable women who are Wills Eye Hospital faculty doctors and former Wills Eye students have been included in the inaugural Power List women's list, published by The Ophthalmologist. Haller, MD, Power List Winner, Chief Ophthalmologist, and William Tasman, MD, Gifted President, Wills Eye Hospital; Professor and Professor of Ophthalmology at Sidney Kimmel Medical College, Thomas Jefferson University.
Wills offers the full range of primary and subspecialized eye care to improve and preserve vision, including cataracts, cornea, retina, emergency care, glaucoma, neuroophthalmology, ocular oncology, oculoplasty, pathology, pediatric ophthalmology and ocular genetics, and refractive surgery. His innovations included plaque radiation therapy, in which a thin piece of metal with radioactive seeds is sewn to the outer wall of the eye to kill a tumor, and radiation surgery with Cyberknife.